Lowe Brockenbrough & Co’s Idexx Laboratories IDXX Stock Holding History

Lowe Brockenbrough & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-752	Closed	-$495K	–	269
2021 Q4	$495K	Buy	752 +49	+7%	+$30.8K	0.04%	199
2021 Q3	$437K	Sell	703 -115	-14%	-$77.3K	0.03%	217
2021 Q2	$517K	Hold	818	–	–	0.05%	180
2021 Q1	$400K	Hold	818	–	–	0.04%	185
2020 Q4	$409K	Sell	818 -82	-9%	-$36.7K	0.04%	175
2020 Q3	$354K	Hold	900	–	–	0.04%	175
2020 Q2	$297K	Hold	900	–	–	0.04%	181
2020 Q1	$218K	Hold	900	–	–	0.04%	190
2019 Q4	$235K	Hold	900	–	–	0.03%	200
2019 Q3	$245K	Sell	900 -85	-9%	-$23.7K	0.03%	196
2019 Q2	$271K	Hold	985	–	–	0.04%	192
2019 Q1	$220K	Buy	+985	New	+$203K	0.03%	200
2018 Q4	–	Sell	-985	Closed	-$246K	–	193
2018 Q3	$246K	Sell	985 -110	-10%	-$26.7K	0.03%	188
2018 Q2	$239K	Hold	1,095	–	–	0.04%	189
2018 Q1	$210K	Buy	+1,095	New	+$202K	0.03%	195
2017 Q4	–	Sell	-1,400	Closed	-$218K	–	198
2017 Q3	$218K	Hold	1,400	–	–	0.03%	192
2017 Q2	$226K	Hold	1,400	–	–	0.04%	186
2017 Q1	$216K	Buy	+1,400	New	+$193K	0.03%	188

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Lowe Brockenbrough & Co's IDXX Position: Q1 2022 in Review

Lowe Brockenbrough & Co sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 752 shares — an estimated $495K sold.

Lowe Brockenbrough & Co first reported a position in IDXX in Q1 2017 and held it in 18 quarters. The position peaked at $517K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Lowe Brockenbrough & Co reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Lowe Brockenbrough & Co sold 752 Idexx Laboratories shares in Q1 2022, an estimated $495K.
Lowe Brockenbrough & Co first reported a position in Idexx Laboratories in Q1 2017 and held it in 18 quarters.
Lowe Brockenbrough & Co's Idexx Laboratories position peaked at $517K in Q2 2021.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2022, filed 4 May 2022.